(605116)"Aurisco Pharmaceutical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 605116 · · 12 pages · Chinese
Aurisco Pharmaceutical Co. Ltd. on 6ix
Earlier from Aurisco Pharmaceutical
- (605116)"Aurisco Pharmaceutical Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Wholly-owned Subsidiary
- Announcement on the Wholly-owned Subsidiary Passing the U.S. FDA On-Site Inspection
- Announcement on the Proposed Selection of the Company's Products in the 12th Batch of National Centralized Drug Procurement
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical